SCHEMBL29620158

SCHEMBL29620158

COc1cc2c(O)cccc2cc1C(=O)O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.77
KDM4E B2RXH2 3/20 0.77
HPGD P15428 2/20 0.77
HSD17B10 Q99714 1/20 0.77
GRIN2D O15399 1/20 0.66
GRIN2A Q12879 1/20 0.66
GRIN2B Q13224 1/20 0.66
GRIN2C Q14957 1/20 0.66
CA12 O43570 2/20 0.54
CA1 P00915 2/20 0.54
CA2 P00918 2/20 0.54
CA7 P43166 2/20 0.54
CA9 Q16790 2/20 0.54
CA14 Q9ULX7 2/20 0.54
CA3 P07451 1/20 0.54
CA4 P22748 1/20 0.54
CA6 P23280 1/20 0.54
CA5A P35218 1/20 0.54
CA5B Q9Y2D0 1/20 0.54
MAOA P21397 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8206713 1.00 ALDH1A1 (0.77) ALDH1A1KDM4EHPGDHSD17B10GRIN2D
SCHEMBL29353299 0.87 ALDH1A1 (1.00) ALDH1A1KDM4EHPGDHSD17B10GRIN2D
SCHEMBL551105 0.87 ALDH1A1 (1.00) ALDH1A1KDM4EHPGDHSD17B10GRIN2D
SCHEMBL17137307 0.86 KDM4E (0.57) ALDH1A1KDM4EHPGDHSD17B10GRIN2D
SCHEMBL17136965 0.86 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDHSD17B10GRIN2D
SCHEMBL24488059 0.86 KDM4E (0.57) ALDH1A1KDM4EHPGDHSD17B10GRIN2D
SCHEMBL27354312 0.84 GRIN2D (0.66) ALDH1A1KDM4EHPGDHSD17B10GRIN2D
SCHEMBL8501456 0.81 KDM4E (0.52) ALDH1A1KDM4EHPGDHSD17B10GRIN2D
SCHEMBL10353592 0.81 GRIN2D (0.82) ALDH1A1KDM4EHPGDHSD17B10GRIN2D
SCHEMBL8207252 0.81 KDM4E (0.77) ALDH1A1KDM4EHPGDHSD17B10GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177446-A1 ALKYNE COMPOUNDS AS IRAK INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF Eternity Bioscience Inc. 2022-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220177446-A1 ALKYNE COMPOUNDS AS IRAK INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF IRAK2, IRAK3, IRAK4 ALDH1A1 2365/4885KDM4E 178/4885HPGD 4023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.